Abstract
Tumor necrosis factor-α (TNF) is a cytokine that induces programmed cell death, apoptosis, in a number of cell types and is employed by cytotoxic T cells to eliminate virus infected cells. Consequently, many viruses have acquired mechanisms to undermine these host cell defense mechanisms and cause resistance to TNF-mediated apoptosis. Here we show that normal human diploid fibroblasts that express the human papillomavirus type 16 E7 oncoprotein have a decreased propensity to undergo apoptosis in response to TNF treatment. The ability of E7 to undermine TNF-mediated apoptosis correlates with cellular transformation. While E7 does not generally subvert signaling by tumor necrosis factor receptor 1, pro-caspase 8 activation is decreased in E7-expressing cells. E7 also provides some protection from apoptosis caused by stimulation of the TNF receptor 1-related cytokine receptor Fas, where induction of apoptosis occurs much slower in this cell type. Hence, E7-expressing normal human fibroblasts exhibit a specific defect that obstructs cytokine-mediated activation of pro-caspase 8 and apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Antwerp D, Martin S, Kafri T, Green D, Verma I . 1996 Science 274: 787–789
Baeuerle PA . 1998 Cell 95: 729–731
Baker SJ, Reddy EP . 1996 Oncogene 12: 1–9
Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W . 1993 Cell 73: 431–445
Boldin MP, Goncharov TM, Goltsev YV, Wallach D . 1996 Cell 85: 803–815
Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D . 1995 J. Biol. Chem. 270: 7795–7798
Boyer SN, Wazer DE, Band V . 1996 Cancer Res. 56: 4620–4624
Bulfone-Pau SS, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R, Krause H . 1999 FASEB J. 13: 1575–1585
Cryns V, Yuan J . 1998 Genes Dev. 12: 1551–1570
D'Arcy A, Banner DW, Janes W, Winkler FK, Loetscher H, Schonfeld HJ, Zulauf M, Gentz R, Lesslauer W . 1993 J. Mol. Biol. 229: 555–557
Demers GW, Espling E, Harry JB, Etscheid BG, Galloway DA . 1996 J. Virol. 70: 6862–6869
Eck MJ, Sprang SR . 1989 J. Biol. Chem. 264: 17595–17605
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S . 1998 Nature 391: 43–50
Foster SA, Demers GW, Etscheid BG, Galloway DA . 1994 J. Virol. 68: 5698–5705
Halbert CL, Demers W, Galloway DA . 1991 J. Virol. 65: 473–478
Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV . 1996 Immunity 4: 387–396
Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J . 1997 Nature 388: 190–195
Jones DL, Münger K . 1997 J. Virol. 71: 2905–2912
Jones DL, Thompson DA, Münger K . 1997 Virology 239: 97–107
Jones DL, Thompson DA, Suh-Burgmann E, Grace M, Munger K . 1999 Virology 258: 406–414
Kirstein M, Fiers W, Baglioni C . 1986 J. Immunol. 137: 2277–2280
Kischkel FC, Hellbart S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME . 1995 EMBO J. 14: 5579–5588
Li H, Zhu H, Xu CJ, Yuan J . 1998 Cell 94: 491–501
Lin Y, Devin A, Rodriguez Y, Liu ZG . 1999 Genes Dev. 13: 2514–2526
Liu X, Zou H, Slaughter C, Wang X . 1997 Cell 89: 175–184
Liu ZG, Hus H, Goeddel DV, Karin M . 1996 Cell 87: 565–576
Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . 1998 Cell 94: 481–490
May MJ, Ghosh S . 1997 Semin. Cancer Biol. 8: 63–73
Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME . 1997 EMBO J. 16: 2794–2804
Miller AD, Rosman GJ . 1989 Bio. Techniques 7: 980–982
Muzio M, Chinnaiyan AM, Kischkel FC, Orourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM . 1996 Cell 85: 817–827
Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM . 1998 J. Biol. Chem. 273: 2926–2930
Opipari Jr, AW, Boguski MS, Dixit VM . 1990 J. Biol. Chem. 265: 14705–14708
Perez D, White E . 1998 J. Cell. Biol. 141: 1255–1266
Pfizenmaier K, Kronke M, Scheurich P, Nagel GA . 1987 Blut 55: 1–10
Phelps WC, Yee CL, Münger K, Howley PM . 1988 Cell 53: 539–547
Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH . 1999 Mol. Cell. 4: 771–781
Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ . 1995 J. Biol. Chem. 270: 7420–7426
Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam S, Ruby JC . 1997 Immunol. Rev. 159: 119–135
Reid TR, Torti FM, Ringold GM . 1989 J. Biol. Chem. 264: 4583–4589
Roulston A, Marcellus RC, Branton PE . 1999 Annu. Rev. Microbiol. 53: 577–628
Roulston A, Reinhard C, Amiri P, Williams LT . 1998 J. Biol. Chem. 273: 10232–10239
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME . 1998 EMBO J. 17: 1675–1687
Scaffidi C, Schmitz I, Krammer PH, Peter ME . 1999 J. Biol. Chem. 274: 1541–1548
Smotkin D, Wettstein OF . 1987 J. Virol. 61: 1686–1689
Stanger BZ, Leder P, Lee TH, Kim E, Seed B . 1995 Cell 81: 513–523
Stoppler H, Stoppler MC, Johnson E, Simbulan-Rosenthal CM, Smulson ME, Iyer S, Rosenthal DS, Schlegel R . 1998 Oncogene 17: 1207–1214
Tartaglia LA, Rothe M, Hu YF, Goeddel DV . 1993 Cell 73: 213–216
Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J . 1997 Nature 386: 517–521
Thompson DA, Belinsky G, Chang TH-T, Jones DL, Schlegel R, Münger K . 1997 Oncogene 15: 3025–3036
Vandevoorde V, Haegeman G, Fiers W . 1997 J. Cell. Biol. 137: 1627–1638
Wakabayashi T, Asada M, Nagasu T, Iijima A, Hasegawa Y, Shikata Y, Kitoh K . 1990 J. Biol. Chem. 265: 7604–7609
Wold WS, Doronin K, Toth K, Kuppuswamy M, Lichtenstein DL, Tollefson AE . 1999 Curr. Opin. Immunol. 11: 380–386
Wong GH, Kamb A, Goeddel DV . 1992 Tumor Necrosis Factors: the Molecules and Their Emerging Role in Medicine Beutler B. (ed. Raven Press: New York pp. 371–381
Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW, Mak TW . 1998 Genes Dev. 12: 806–819
Acknowledgements
We are grateful to Arthur Lee and Philip Hinds for critical comments concerning this manuscript. We also thank D Galloway, W Krek, V Dixit, M Oren R Mulligan, E Kieff, J Daniels, R Ed Marlborough and TH-T Chang for providing important reagents and support. This work was supported by Public Health Service grant R01 CA81135 (K Münger) from the National Cancer Institute. V Zacny was supported by T32 CA72320. K Münger is a Ludwig Scholar; DA Thompson is a Ryan fellow.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thompson, D., Zacny, V., Belinsky, G. et al. The HPV E7 oncoprotein inhibits tumor necrosis factor α-mediated apoptosis in normal human fibroblasts. Oncogene 20, 3629–3640 (2001). https://doi.org/10.1038/sj.onc.1204483
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204483
Keywords
This article is cited by
-
The polymorphism analysis and epitope predicted of Alphapapillomavirus 9 E6 in Sichuan, China
Virology Journal (2022)
-
The modulation of apoptosis by oncogenic viruses
Virology Journal (2013)
-
Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53
Apoptosis (2011)
-
Ubiquitination in host immune response to human papillomavirus infection
Archives of Dermatological Research (2011)
-
Molecular mechanisms of hyperplasia induction by human papillomavirus E7
Oncogene (2006)